Suppr超能文献

我们在复发性肝细胞癌患者中重复腹腔镜肝切除的经验。

Our experience of repeat laparoscopic liver resection in patients with recurrent hepatocellular carcinoma.

机构信息

Department of Surgery, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai, Osaka, 593-8304, Japan.

Department of Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-3-1 Aoyamacho, Kure, Hiroshima, 737-0023, Japan.

出版信息

Surg Endosc. 2020 May;34(5):2113-2119. doi: 10.1007/s00464-019-06992-8. Epub 2019 Jul 18.

Abstract

BACKGROUND

Repeat liver resection is an effective treatment approach for patients with recurrent hepatocellular cell carcinoma (HCC). However, the surgical feasibility and oncological significance of repeat laparoscopic liver resection (r-LLR) remain unproven. This study evaluates and compares the clinical outcomes of non-anatomic r-LLR applied towards recurrent HCC, with those of primary LLR (p-LLR) for primary HCC.

METHODS

This retrospective study reports 104 patients with HCC, treated with LLR between 2014 and 2018. Twenty eight of these patients underwent r-LLR for recurrent HCC. The clinical and surgical variables were reviewed for all cases.

RESULTS

The analysis was limited to non-anatomic resection across both groups (r-LLR: 89% (25/28) vs. p-LLR: 80% (61/76)). There were no statistically significant differences about patient background between the two groups, with the exception of Child-Pugh classification. r-LLR surgical techniques included single-site laparoscopic adhesiolysis (32%, 8/25), Pringle maneuver (8%, 2/25), and crush-clamp method using BiClamp for hepatic parenchymal transection (72%, 18/25). No severe postoperative complications were observed in the r-LLR group. Postoperative hospital stays and procedure-related postoperative survival were similar for both groups.

CONCLUSIONS

Non-anatomical r-LLR renders comparable surgical and oncological outcomes. Our data suggest that non-anatomical r-LLR is a safe and feasible therapeutic approach to recurrent HCC.

摘要

背景

对于复发性肝细胞癌(HCC)患者,重复肝切除术是一种有效的治疗方法。然而,重复腹腔镜肝切除术(r-LLR)的手术可行性和肿瘤学意义尚未得到证实。本研究评估和比较了非解剖性 r-LLR 治疗复发性 HCC 与原发性 HCC 原发性 LLR(p-LLR)的临床结果。

方法

本回顾性研究报告了 2014 年至 2018 年间接受 LLR 治疗的 104 例 HCC 患者。其中 28 例患者因复发性 HCC 而行 r-LLR。对所有病例的临床和手术变量进行了回顾性分析。

结果

分析仅限于两组的非解剖性切除(r-LLR:89%(25/28)与 p-LLR:80%(61/76))。两组患者的背景无统计学差异,除了 Child-Pugh 分级。r-LLR 手术技术包括单部位腹腔镜粘连松解术(32%,8/25)、Pringle 手法(8%,2/25)和 BiClamp 压夹法肝实质横断术(72%,18/25)。r-LLR 组无严重术后并发症。两组术后住院时间和与手术相关的术后生存率相似。

结论

非解剖性 r-LLR 可获得相似的手术和肿瘤学结果。我们的数据表明,非解剖性 r-LLR 是治疗复发性 HCC 的一种安全可行的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验